UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 28, 2016

Accession Number:	0001104659-16-113822
Submission Type:	POS AM
CIK: 0001130598 Company Name: Onconova Therapeutics, Inc. File Number: 333-207533